Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence

Female Pelvic Medicine and Reconstructive Surgery

Volumn 21, Issue 3, 2015, Pages 154-159

  Kunkle, Cynelle M ^a   Hallock, Jennifer L ^a   Hu, Xiaohan ^b   Blomquist, Joan ^c   Thung, Stephen F ^d   Werner, Erika F ^a,e  

^a University School of Medicine   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GREATER BALTIMORE MEDICAL CENTER   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

bulking agents; cost utility; midurethral sling; stress incontinence; urethral hypermobility

Indexed keywords

BULKING AGENT; BIOMATERIAL; POLYMER;

ARTICLE; BLADDER INJURY; BLEEDING; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DECISION TREE; DRUG TREATMENT FAILURE; DYSURIA; HEALTH CARE COST; HEMATOMA; HEMATURIA; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DEVICE COMPLICATION; MESH COMPLICATION; MONTE CARLO METHOD; PAIN; RECURRENT DISEASE; RECURRENT INFECTION; SENSITIVITY ANALYSIS; STRESS INCONTINENCE; SUBURETHRAL SLING; THIGH PAIN; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE RETENTION; ADULT; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; FEMALE; MEDICARE; POSTOPERATIVE COMPLICATION; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES; URINARY INCONTINENCE, STRESS;

ADULT; BIOCOMPATIBLE MATERIALS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MEDICARE; MONTE CARLO METHOD; POLYMERS; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBURETHRAL SLINGS; UNITED STATES; URINARY INCONTINENCE, STRESS;

EID: 84928947945     PISSN: 21518378     EISSN: 21544212     Source Type: Journal    
DOI: 10.1097/SPV.0000000000000173     Document Type: Article

References (52)

1. Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol. 2004; 6(Suppl 3): S3-S9
2. Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the Sickness Impact Profile. J Am Geriatr Soc. 1991; 39(4): 378-382
3. Birnbaum, Leong SA, Oster EF, et al. Cost of stress urinary incontinence. Pharmacoeconomics. 2004; 22(2): 95-105
4. Wilson L, Brown JS, Shin GP, et al. Annual direct cost of urinary incontinence. Obstet Gynecol. 2011; 98: 398-406
5. Kane AR, Nager CW. Midurethral slings for stress urinary incontinence. Clin Obstet Gynecol. 2008; 51(1): 124-135
6. Anger JT, Weinberg AE, Albo ME, et al. Trends in surgical management of stress urinary incontinence among female Medicare beneficiaries. Urology. 2009; 74(2): 283-287
7. Leach GE, Dmochowski RR, Appell RA, et al. Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J Urol. 1997; 158(3 Pt 1): 875-880
8. Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2009; (4). CD006375
9. Ward KL, Hilton PUK and Ireland TVT Trial Group. Tension-free vaginal tape versus colposuspension for primary urodynamic stress incontinence: 5-year follow up. BJOG. 2008; 115(2): 226-233
10. Jelovsek JE, Barber MD, Karram MM, et al. Randomized trial of laparoscopic Burch colposuspension versus tension-free vaginal tape: long-Term follow up. BJOG. 2008; 115(2): 219-225
11. Delancey JO. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol. 1994; 170(6): 1713-1720 discussion 1720-1723
12. Parden AM, Gleason JL, Jauk V, et al. Incontinence outcomes in women undergoing primary and repeat midurethral sling procedures. Obstet Gynecol. 2013; 121(2 Pt 1): 273-278
13. Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol. 2008; 180(5): 1890-1897
14. Dmochowski RR, Blaivas JM, Gormley EA, et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010; 183(5): 1906-1914
15. Lightner D, Fox J. Bulking agents for urinary incontinence: patient selection, counseling and technique. Expert Rev Obstet Gynecol. 2009; 4(6): 687-694
16. Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2012; 2. CD003881
17. Maher CF, O'Reilly BA, Dwyer PL, et al. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG. 2005; 112(6): 797-801
18. Corcos J, Collet JP, Shapiro S, et al. Multicenter randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology. 2005; 65(5): 898-904
19. Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med. 2010; 362(22): 2066-2076
20. Persson J, Teleman P, Eté n-Bergquist C, et al. Cost-Analyzes based on a prospective, randomized study comparing laparoscopic colposuspension with a tension-free vaginal tape procedure. Acta Obstet Gynecol Scand. 2002; 81: 1066-1073
21. Aniuliene R. Tension-free vaginal tape versus tension-free vaginal tape obturator (inside-outside) in the surgical treatment of female stress urinary incontinence. Medicina (Kaunas) 2009; 45: 639-643
22. Freeman R, Holmes D, Hillard T, et al. What patients think: patient-reported outcomes of retropubic versus transobturator mid-urethral slings for urodynamic stress incontinence: a multicenter randomized controlled trial. Int Urogynecol J 2011; 22: 279-286
23. Krofta L, Feyereisl J, Otcená sek M, et al. TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial. Int Urogynecol J 2010; 21: 141-148
24. Liapis A, Bakas P, Giner M, et al. Tension-free vaginal tape versus tension-free vaginal tape obturator in women with stress urinary incontinence. Gynecol Obstet Invest. 2006; 62: 160-164
25. Scheiner DA, Betschart C, Wiederkehr S, et al. Twelve months effect on voiding function of retropubic compared with outside-in and inside-out transobturator midurethral slings. Int Urogynecol J 2012; 23: 197-206
26. Teo R, Moran P, Mayne C, et al. Randomized trial of tension-free vaginal tape and tension-free vaginal tape-obturator for urodynamic stress incontinence in women. J Urol. 2011; 185: 1350-1355
27. Wang F, Song Y, Huang H. Prospective randomized trial of TVT and TOT as primary treatment for female stress urinary incontinence with or without pelvic organ prolapse in Southeast China. Arch Gynecol Obstet. 2010; 281: 279-286
28. Wang YJ, Li FP, Wang Q, et al. Comparison of three mid-urethral tension-free tapes (TVT, TVT-O, and TVT-Secur) in the treatment of female stress urinary incontinence: 1-year follow-up. Int Urogynecol J 2011; 22: 1369-1374
29. Andonian S, Chen T, St-Denis B, et al. Randomized clinical trial comparing suprapubic arch sling (SPARC) and tension-free vaginal tape (TVT): one-year results. Eur Urol. 2005; 47: 537-541
30. Abdel-Fattah M, Ramsay I, Pringle S, et al. Randomized prospective single-blinded study comparing "inside-out" versus "outside-in" transobturator tapes in the management of urodynamic stress incontinence: 1-year outcomes from the E-TOT study. BJOG. 2010; 117: 870-878
31. Barber MD, Weidner AC, Sokol AI, et al. Single-incision mini-sling compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol. 2012; 119: 328-337
32. Bai SW, SohnWH, Chung DL, et al. Comparison of the efficacy of Burch colposuspension, pubovaginal sling, and research urogynecology tension-free vaginal tape for stress urinary incontinence. Int J Gynaecol Obstet. 2005; 91: 246-251
33. Hinoul P, Vervest HA, den Boon J, et al A randomized, controlled trial comparing an innovative single incision sling with an established transobturator sling to treat female stress urinary incontinence.JUrol. 2011; 185: 1356-1362
34. Tommaselli GA, Di Carlo C, Gargano V, et al. Efficacy and safety of TVT-O and TVT-Secur in the treatment of female stress urinary incontinence: 1-year follow-up. Int Urogynecol J 2010; 21: 1211-1217
35. Ross S, Robert M, Swaby C, et al. Transobturator tape compared with tension-free vaginal tape for stress incontinence: a randomized controlled trial. Obstet Gynecol. 2009; 114: 1287-1294
36. Oliveira R, Botelho F, Silva P, et al. Exploratory study assessing efficacy and complications of TVT-O, TVT-Secur, and Mini-Arc: results at 12-month follow-up. Eur Urol. 2011; 59: 940-944
37. Guerrero KL, Emery SJ, Wareham K, et al A randomized controlled trial comparing TVT, Pelvicol, and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG. 2010; 117: 1493-1503
38. Hota LS, Hanaway K, Hacker MR, et al. TVT-Secur (hammock) versus TVT-obturator: a randomized trial of suburethral sling operative procedures. Female Pelvic Med Reconstr Surg. 2012; 18: 41-45
39. Richter HE, Litman HJ, Lukacz ES, et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol. 2011; 117(4): 913-921
40. Fritel X, Zabak K, Pigne A, et al. Predictive value of urethral mobility before suburethral tape procedure for urinary stress incontinence inwomen. J Urol. 2002; 168(6): 2472-2475
41. LiapisA, Bakas P, Creatsas G. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Eur Urol. 2009; 55(6): 1450-1455
42. Toledo LG, Cabral PH, Casella ML, et al. Prognostic value of urethral mobility and Valsalva leak point pressure for female transobturator sling procedure. Int Braz J Urol. 2012; 38(5): 667-673
43. Ghoniem G, Corcos J, Comiter C, et al. Crosslinked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study. J Urol. 2009; 181: 204
44. Meulen PH, Berghmans LC, Nieman FH, et al. Effects of Macroplastique Implantation System for stress urinary incontinence and urethral hypermobility in women. Int Urogynecol J 2009; 20(2): 177-183
45. Mayer RD, Dmochowski RR, Appell RA, et al. Multicenter prospective randomized 52-week trial of calcium hydroxylapatite versus bovine dermal collagen for treatment of stress urinary incontinence. Urology. 2007; 69(5): 876-880
46. Bano F, Barrington JW, Dyer R. Comparison between porcine dermal implant (Permacol) and silicone injection (Macroplastique) for urodynamic stress incontinence. Int Urogynecol J 2005; 16: 147-150
47. Lightner D, Calvosa C, Andersen R, et al A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled double-blind study of Durasphere. Urology. 2001; 58: 12
48. Anders K, Khullar V, Cardozo L, et al. Contigen or Macroplastique? A five year follow-up (Abstract). In: Proceedings of the International Continence Society, 32nd Annual Meeting; 2002 Aug 28-30. Heidelberg, Germany: International Continence Society; 2002: 183-184
49. Ghoniem G, Corcos J, Comiter C, et al. Durability of urethral bulking agent injection for female stress urinary incontinence: 2-year multicenter study results. J Urol. 2010; 183: 1444-1449
50. Andersen RCM. Long-Term follow-up comparison of Durasphere (trademark) and Contigen (trademark) in the treatment of stress urinary incontinence. J Low Genit Tract Dis. 2002; 6(4): 239-243
51. Shepherd JP, Lowder JL, Jones KA, et al. Retropubic and transobturator midurethral slings: a decision analysis to compare outcomes including efficacy and complications. Int Urogynecol J 2010; 21(7): 787-793
52. Subak LL, Brown JS, Kraus SR, et al. Diagnostic Aspects of Incontinence Study Group. The "costs" of urinary incontinence for women. Obstet Gynecol. 2006; 107(4): 908-916